The effects of oral contraceptives and parity on ovarian cancer trends in women under 55 years of age
- 1 July 1989
- journal article
- research article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 96 (7) , 783-788
- https://doi.org/10.1111/j.1471-0528.1989.tb03316.x
Abstract
Summary. Mortality from epithelial ovarian cancer is falling in women under 55 years of age in England and Wales. The decline does not appear to be a treatment effect nor to be attributable to changes in the rate of oophorectomy. Case-control studies have shown that high parity and oral contraceptive use are protective against the disease. We suggest that the decrease in mortality is compatible in timing and magnitude with exposure to oral contraceptives. No obvious effect on mortality attributable to parity was apparent in this analysis. Oral contraceptives may prove to be a widely acceptable means of preventing ovarian cancer, providing they do not increase breast cancer risk.Keywords
This publication has 11 references indexed in Scilit:
- Long-term survival experience of female patients with genital cancerBritish Journal of Cancer, 1988
- CIGARETTE SMOKING AND THE RISK OF EPITHELIAL OVARIAN CANCER1American Journal of Epidemiology, 1987
- The Reduction in Risk of Ovarian Cancer Associated with Oral-Contraceptive UseNew England Journal of Medicine, 1987
- Epithelial Ovarian Cancer and Coffee DrinkingInternational Journal of Epidemiology, 1987
- THE INFLUENCE OF AGE AT FIRST BIRTH AND PARITY ON OVARIAN CANCER RISKAmerican Journal of Epidemiology, 1986
- Factors Affecting the Association of Oral Contraceptives and Ovarian CancerNew England Journal of Medicine, 1982
- "INCESSANT OVULATION" AND OVARIAN CANCERThe Lancet, 1979
- Hysterectomy rates and their influence upon mortality from carcinoma of the cervix.Journal of Epidemiology and Community Health, 1978
- DOES PREGNANCY PROTECT AGAINST OVARIAN CANCER?The Lancet, 1978